64.00
+4.00
+(6.67%)
At close: April 10 at 5:19:20 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 1B | 1.11B | 4.15B | 4.52B |
| Low Estimate | 1B | 1.11B | 4.15B | 4.52B |
| High Estimate | 1B | 1.11B | 4.15B | 4.52B |
| Year Ago Sales | 849.65M | 997.75M | 3.77B | 4.15B |
| Sales Growth (year/est) | 18.05% | 11.15% | 10.20% | 8.86% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MUD.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Downgrade | Northcoast Research: Buy to Neutral | 1/19/2024 |
| Initiated | Boenning & Scattergood: Neutral | 5/18/2018 |
| Downgrade | Buckingham Research: Buy to Neutral | 2/6/2014 |
| Downgrade | Monness, Crespi, Hardt: Buy to Neutral | 11/1/2013 |
| Maintains | Monness, Crespi, Hardt: Buy | 2/6/2013 |
| Upgrade | Buckingham Research: Neutral to Buy | 10/1/2012 |